213 related articles for article (PubMed ID: 7824944)
1. Researchers broaden the attack on Parkinson's disease.
Barinapa M
Science; 1995 Jan; 267(5197):455-6. PubMed ID: 7824944
[No Abstract] [Full Text] [Related]
2. Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor.
Espejo M; Cutillas B; Arenas TE; Ambrosio S
Cell Transplant; 2000; 9(1):45-53. PubMed ID: 10784066
[TBL] [Abstract][Full Text] [Related]
3. Graft survival.
Brundin P; Petersén A; Hansson O
J Neurosurg; 1999 Apr; 90(4):804-6. PubMed ID: 10193633
[No Abstract] [Full Text] [Related]
4. Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts.
Sautter J; Tseng JL; Braguglia D; Aebischer P; Spenger C; Seiler RW; Widmer HR; Zurn AD
Exp Neurol; 1998 Jan; 149(1):230-6. PubMed ID: 9454632
[TBL] [Abstract][Full Text] [Related]
5. Temporal changes in the neurotrophic environment of the denervated striatum as determined by the survival and outgrowth of grafted fetal dopamine neurons.
Yurek DM; Fletcher-Turner A
Brain Res; 2002 Mar; 931(2):126-34. PubMed ID: 11897098
[TBL] [Abstract][Full Text] [Related]
6. A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease.
Carvey PM; Ling ZD; Sortwell CE; Pitzer MR; McGuire SO; Storch A; Collier TJ
Exp Neurol; 2001 Sep; 171(1):98-108. PubMed ID: 11520124
[TBL] [Abstract][Full Text] [Related]
7. Enhanced survival, reinnervation, and functional recovery of intrastriatal dopamine grafts co-transplanted with Schwann cells overexpressing high molecular weight FGF-2 isoforms.
Timmer M; Müller-Ostermeyer F; Kloth V; Winkler C; Grothe C; Nikkhah G
Exp Neurol; 2004 May; 187(1):118-36. PubMed ID: 15081594
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of graft survival and sensorimotor behavioral recovery in rats undergoing transplantation with dopaminergic cells exposed to glial cell line-derived neurotrophic factor.
Mehta V; Hong M; Spears J; Mendez I
J Neurosurg; 1998 Jun; 88(6):1088-95. PubMed ID: 9609305
[TBL] [Abstract][Full Text] [Related]
9. Strands of embryonic mesencephalic tissue show greater dopamine neuron survival and better behavioral improvement than cell suspensions after transplantation in parkinsonian rats.
Clarkson ED; Zawada WM; Adams FS; Bell KP; Freed CR
Brain Res; 1998 Sep; 806(1):60-8. PubMed ID: 9739108
[TBL] [Abstract][Full Text] [Related]
10. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons.
Lin LF; Doherty DH; Lile JD; Bektesh S; Collins F
Science; 1993 May; 260(5111):1130-2. PubMed ID: 8493557
[TBL] [Abstract][Full Text] [Related]
11. [Surgical therapy for Parkinson's disease].
Tomita S; Date I; Ohmoto T
No To Shinkei; 2000 Nov; 52(11):947-58. PubMed ID: 11215268
[No Abstract] [Full Text] [Related]
12. Clinical application of neuronal grafts in Parkinson's disease.
Lindvall O
J Neurol; 1994 Dec; 242(1 Suppl 1):S54-6. PubMed ID: 7699411
[TBL] [Abstract][Full Text] [Related]
13. Stem cells in the treatment of Parkinson's disease.
Arenas E
Brain Res Bull; 2002 Apr; 57(6):795-808. PubMed ID: 12031276
[TBL] [Abstract][Full Text] [Related]
14. Will embryonic stem cells be a useful source of dopamine neurons for transplant into patients with Parkinson's disease?
Freed CR
Proc Natl Acad Sci U S A; 2002 Feb; 99(4):1755-7. PubMed ID: 11854478
[No Abstract] [Full Text] [Related]
15. Protection of dopamine neurons by bone marrow stromal cells.
Shintani A; Nakao N; Kakishita K; Itakura T
Brain Res; 2007 Dec; 1186():48-55. PubMed ID: 17996227
[TBL] [Abstract][Full Text] [Related]
16. Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats.
Zawada WM; Zastrow DJ; Clarkson ED; Adams FS; Bell KP; Freed CR
Brain Res; 1998 Mar; 786(1-2):96-103. PubMed ID: 9554968
[TBL] [Abstract][Full Text] [Related]
17. Neural transplantation in Parkinson's disease: the Swedish experience.
Lindvall O; Rehncrona S; Brundin P; Gustavii B; Astedt B; Widner H; Lindholm T; Björklund A; Leenders KL; Rothwell JC
Prog Brain Res; 1990; 82():729-34. PubMed ID: 2290977
[No Abstract] [Full Text] [Related]
18. Cell therapy for Parkinson's disease.
Fischbach GD; McKhann GM
N Engl J Med; 2001 Mar; 344(10):763-5. PubMed ID: 11236783
[No Abstract] [Full Text] [Related]
19. Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons.
Terpstra BT; Collier TJ; Marchionini DM; Levine ND; Paumier KL; Sortwell CE
J Neurosci Methods; 2007 Oct; 166(1):13-9. PubMed ID: 17706789
[TBL] [Abstract][Full Text] [Related]
20. Neuroscience. Fetal cells again?
Holden C
Science; 2009 Oct; 326(5951):358-9. PubMed ID: 19833936
[No Abstract] [Full Text] [Related]
[Next] [New Search]
